Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BUL | Ann: Investor Presentation-BUL.AX | 07/06/22 | 43 | 25K | |||
|
|||||||
BUL | Future Gas demand | 21/03/21 | 21 | 18K | |||
|
|||||||
BUL | China increases imports? What does this mean? | 15/04/19 | 19 | 11K | |||
|
|||||||
BUL | booming blue | 04/04/19 | 18 | 17K | |||
|
|||||||
BUL | News email today from Gas Today | 27/03/19 | 15 | 10K | |||
|
|||||||
BUL | Ann: Energy and Minerals Conference Presentation | 27/03/19 | 8 | 5.7K | |||
|
|||||||
BUL | Will the Penny drop? | 21/03/19 | 12 | 8.5K | |||
|
|||||||
BUL | cap raise? | 16/03/19 | 21 | 14K | |||
|
See All Discussions